ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 280 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $204,982 | -68.4% | 7,773 | -63.6% | 0.00% | -100.0% |
| Q1 2024 | $647,988 | +20.5% | 21,336 | +11.5% | 0.00% | – |
| Q4 2023 | $537,699 | -96.3% | 19,142 | -96.4% | 0.00% | -100.0% |
| Q3 2023 | $14,406,835 | -11.4% | 530,834 | +0.4% | 0.01% | -13.3% |
| Q2 2023 | $16,260,015 | -15.8% | 528,953 | -1.3% | 0.02% | -16.7% |
| Q1 2023 | $19,310,891 | -10.1% | 535,967 | -1.4% | 0.02% | -14.3% |
| Q4 2022 | $21,477,579 | -0.9% | 543,461 | +0.8% | 0.02% | -8.7% |
| Q3 2022 | $21,663,000 | -4.4% | 539,143 | +0.0% | 0.02% | 0.0% |
| Q2 2022 | $22,661,000 | +51.1% | 539,034 | +40.1% | 0.02% | +76.9% |
| Q1 2022 | $14,994,000 | +2985.2% | 384,844 | +3748.4% | 0.01% | +1200.0% |
| Q2 2020 | $486,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $263,446,000 | 59.92% |
| Memorial Sloan Kettering Cancer Center | 1,128,255 | $43,957,000 | 50.90% |
| Vantage Consulting Group Inc | 2,727,854 | $106,277,000 | 41.47% |
| Indie Asset Partners, LLC | 756,874 | $29,488,000 | 22.15% |
| Overbrook Management Corp | 723,250 | $28,178,000 | 6.25% |
| Brown University | 621,759 | $24,224,000 | 5.93% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $8,527,000 | 3.82% |
| Lagoda Investment Management, L.P. | 141,560 | $5,515,000 | 2.97% |
| Greytown Advisors Inc. | 131,143 | $5,109,000 | 2.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,025,610 | $78,918,000 | 2.41% |